Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Silverview Credit Partners
investor
United States
- Tampa, Florida
- 18/11/2022
- Unknown
- $20,000,000
We are your leaders in lower middle market capital solutions.
Silverview Credit Partners specializes in debt transactions between $10mm and $30mm.
- Industry Investment Management
- Website https://www.silverviewcredit.com/
- LinkedIn https://www.linkedin.com/company/silverview-credit-partners/about/
Related People
Jeffrey MarcusInvestor
United States -
Hartsdale, New York,
Silverview Credit Partners LP (“Silverview”) was founded in 2015 by former senior team members of UBS’ Legacy Investment Bank. Silverview is a registered investment advisor specialized in seeking to identify differentiated special situations lending opportunities in the non-sponsored, lower middle market space. Silverview has built an intricate process to source, underwrite, and fund $10-$30 million loan opportunities through the family of funds it manages.
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)